Human CellExp™ CD30 Ligand / TNFSF8, Human Recombinant

(No reviews yet) Write a Review
Usually Shipped in 5 Working Days
Storage Temperature:
Shipping Conditions:
Gel Pack
Shelf Life:
12 months
€191.00 - €555.00
Frequently bought together:


Biomolecule/Target: N/A

Synonyms: CD30-L, CD153, TNFSF8, CD30L, CD30LG, CD153 antigen, CD30 antigen ligand, CD30 Ligand

Alternates names: CD30-L, CD153, TNFSF8, CD30L, CD30LG, CD153 antigen, CD30 antigen ligand, CD30 Ligand

Taglines: A ligand for TNFRSF8/CD30, which is a cell surface antigen

Taglines: USA

Country of Animal Origin: USA

NCBI Gene ID #.: 944

NCBI Gene Symbol: TNFSF8

Gene Source: Human

Accession #: P32971

Recombinant: True

Source: HEK 293 cells

Purity by SDS-PAGE #: >90%


Purity: N/A

Assay #2: N/A

Endotoxin Level: Less than 1.0 EU per μg by the LAL method.

Activity (Specifications/test method): N/A

Biological activity: N/A

Results: N/A

Binding Capacity: N/A

Unit Definition: N/A

Molecular Weight: This protein carries a polyhistidine tag at the N-terminus. The protein has a calculated MW of 21.5 kDa. The protein migrates as 30-40 kDa under reducing (R) condition (SDS-PAGE) due to glycosylation.

Concentration: N/A

Appearance: Lyophilized powder

Physical form description: Lyophilized

Reconstitution Instructions: Reconstitute in sterile deionized water to the desired protein concentration.

Background Information: CD30 ligand (CD30L) and CD30 are interacting cellsurface glycoproteins that are members of the tumour necrosis factor (TNF) and tumour necrosis factor receptor (TNFR) superfamilies. In humans, CD30L is expressed at high levels on activated T cells. There is conflicting evidence with regard to cell surface expression of CD30L on primary human B cells. An initial report of constitutive CD30L expression on peripheral blood B cells33 has not been substantiated.

Amino acid sequence: Gln 63 - Asp 234

Handling: Centrifuge the vial prior to opening.

Usage: N/A

View AllClose